Cardiac Data Articles & Analysis
18 news found
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS partners that provide software solutions that run on or integrate with AWS. ...
A key presentation highlights new clinical data on the novel development compound gadoquatrane, a next generation macrocyclic gadolinium-based contrast agent (GBCA) which is currently in Phase II of clinical development and planned to enter Phase III later this year. ...
ByBayer AG
The technology is intended to be convenient and requires only 20 seconds each morning, and should easily lend itself to integration into a daily routine. The device can transmit the data on cardiac hemodynamic parameters to clinicians through cellular networks, and uses AI-based algorithms to identify a variety of hemodynamic biomarkers to aid in early ...
iRhythm Technologies has presented new data on its Zio wearable cardiac monitoring device at the American College of Cardiology (ACC) 71st Annual Scientific Session & Expo, building the clinical case for its devices. ...
One-Year Final Data Highlights Lead Cell Therapy Asset, CAP-1002, for Safety and Efficacy in Slowing Upper Limb and Cardiac Function Deterioration in Patients Data Sets Stage for Pivotal Phase 3 HOPE-3 Clinical Trial Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and ...
Double-blind, randomized trial data show a clinically meaningful and statistically significant net reduction of 8.1 mmHg in 24-hour ambulatory systolic blood pressure at 6 months in treated vs. control patients Very high (85%) response rate to therapy despite 81% of treated patients having isolated systolic hypertension (ISH), a more dangerous and difficult to treat form of ...
An analysis of 48,570 cardiac cycles revealed that monitoring stroke volume change via carotid Doppler might support the diagnosis and management of evolving hypovolemia Flosonics Medical recently announced a study published in the British Journal of Anaesthesia in which Dr. ...
With the patient friendly Coala, we can now follow our patients and review diagnostic quality cardiac data as long as it’s medically necessary.” ...
BioSerenity also offers hospitals comprehensive Neurodiagnostic Solutions inclusive of state-of-the-art medical devices for electroencephalogram (EEG) testing including FDA cleared Neuronaute® and IceCap® devices, clinical and administrative services including patient monitoring, and secure cloud-based platforms for data access and management. Cardiac ...
Coala Life, the award-winning Swedish innovator of real-time remote cardiac monitoring solutions announces the launch of Coala Connect Rx. ...
We are excited to announce the development of a visual genomic data portal to support the University of Utah. The University currently hosts more than 19,000 exomes and 8,000 genomes from over 7,000 different families. This includes data from the Pediatric Cardiac Genomics Consortium (NHLBI), the Undiagnosed Disease Network (NIH), the Sudden ...
SEATTLE, May 26, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it received CE mark certification for the 14-Day version of the Carnation Ambulatory Monitor (“CAM”) patch, the industry’s only P-wave centric ...
Seattle, WA — March 25, 2020 — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today that its Carnation Ambulatory Monitor (“CAM™”) Patch has been chosen for use in protocols to measure QT Segments in COVID-19 patients who have ...
Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure (HF), today announced the findings of a post hoc analysis of pooled prospectively collected data from three studies of the Carillon Mitral Contour System® with a focus on 5-year survival rate and ...
Both patents are entitled “Methods for Evaluating Regional Cardiac Function and Dyssynchrony from a Dynamic Imaging Modality using Endocardial Motion,” and were awarded to The Johns Hopkins University (JHU) for its pioneering work on a mathematical software algorithm that utilizes cardiac Computed Tomography (CT) data to determine the ...
Casciaro, President and CEO of Cardiac Dimensions. “It was not long ago that surgical intervention was the final solution to treating FMR. ...
Cardiac Dimensions, a leader in the development of minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, presented data at the TVT2019 Structural Heart Summit showing increased mitral valve tenting is associated with an improvement in regurgitant volume with the Carillon Mitral Contour System®. ...
The US Patent application was filed November 11, 2016. The software uses cardiac CT patient data sets to determine which heart failure patients may benefit from implantation of a Cardiac Resynchronization Therapy device and can guide the placement of leads to ensure that the device is effective. ...